Sarah James
Stock Analyst at Cantor Fitzgerald
(1.94)
# 3,175
Out of 4,996 analysts
287
Total ratings
34.55%
Success rate
-7.83%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Reiterates: Overweight | $440 | $344.08 | +27.88% | 18 | Aug 26, 2025 | |
| UHS Universal Health Services | Reiterates: Neutral | $227 | $200.85 | +13.02% | 25 | Aug 26, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $190 | $202.00 | -5.94% | 21 | Aug 26, 2025 | |
| MOH Molina Healthcare | Reiterates: Neutral | $210 | $191.98 | +9.39% | 13 | Aug 26, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $444 | $419.08 | +5.95% | 20 | Aug 26, 2025 | |
| CVS CVS Health | Reiterates: Overweight | $78 | $75.77 | +2.94% | 15 | Aug 26, 2025 | |
| CNC Centene | Reiterates: Neutral | $38 | $34.86 | +9.01% | 15 | Aug 26, 2025 | |
| CI The Cigna Group | Reiterates: Overweight | $365 | $286.17 | +27.55% | 22 | Aug 26, 2025 | |
| PGNY Progyny | Maintains: Overweight | $26 → $28 | $21.46 | +30.48% | 15 | Aug 8, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $9 → $4 | $2.80 | +42.86% | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $290 | $254.95 | +13.75% | 21 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $318.61 | +52.22% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $52 → $40 | $24.53 | +63.07% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $20.48 | +41.60% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $6.43 | +133.28% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $21.84 | +96.89% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $1.37 | +264.96% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $8.16 | +22.55% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $130.80 | +1.68% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $21.05 | +99.52% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $4.79 | +4.38% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $8.75 | -42.86% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $17.53 | +19.79% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $75.91 | -48.62% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $66.04 | +192.25% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.18 | - | 2 | Mar 1, 2017 |
UnitedHealth Group
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $344.08
Upside: +27.88%
Universal Health Services
Aug 26, 2025
Reiterates: Neutral
Price Target: $227
Current: $200.85
Upside: +13.02%
Tenet Healthcare
Aug 26, 2025
Reiterates: Overweight
Price Target: $190
Current: $202.00
Upside: -5.94%
Molina Healthcare
Aug 26, 2025
Reiterates: Neutral
Price Target: $210
Current: $191.98
Upside: +9.39%
HCA Healthcare
Aug 26, 2025
Reiterates: Overweight
Price Target: $444
Current: $419.08
Upside: +5.95%
CVS Health
Aug 26, 2025
Reiterates: Overweight
Price Target: $78
Current: $75.77
Upside: +2.94%
Centene
Aug 26, 2025
Reiterates: Neutral
Price Target: $38
Current: $34.86
Upside: +9.01%
The Cigna Group
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $286.17
Upside: +27.55%
Progyny
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $21.46
Upside: +30.48%
Health Catalyst
Aug 8, 2025
Downgrades: Neutral
Price Target: $9 → $4
Current: $2.80
Upside: +42.86%
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $254.95
Upside: +13.75%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $318.61
Upside: +52.22%
Apr 3, 2025
Maintains: Neutral
Price Target: $52 → $40
Current: $24.53
Upside: +63.07%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $20.48
Upside: +41.60%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $6.43
Upside: +133.28%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $21.84
Upside: +96.89%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $1.37
Upside: +264.96%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $8.16
Upside: +22.55%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $130.80
Upside: +1.68%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $21.05
Upside: +99.52%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $4.79
Upside: +4.38%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $8.75
Upside: -42.86%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $17.53
Upside: +19.79%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $75.91
Upside: -48.62%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $66.04
Upside: +192.25%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.18
Upside: -